欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/2293/001
药品名称Meropenem Star Pharmasin
活性成分
    • Meropenem 500.0 mg
剂型Powder for solution for injection/infusion
上市许可持有人Star Pharmasin Limited
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Ireland (IE)
    • Italy (IT)
    • Latvia (LV)
      Meropenem Venus Pharma 500 mg pulveris injekciju/infūziju šķīduma pagatavošanai
    • Bulgaria (BG)
      Meropenem Enexi
    • Lithuania (LT)
      Meropenem Venus Pharma 500 mg milteliai injekciniam ar infuziniam tirpalui
    • Estonia (EE)
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Finland (FI)
    • Iceland (IS)
    • Norway (NO)
    • Sweden (SE)
许可日期2020/10/29
最近更新日期2024/10/08
药物ATC编码
    • J01DH02 meropenem
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase